COR - Cencora, Inc.
291.97
-0.150 -0.051%
Share volume: 1,385,562
Last Updated: 05-05-2025
Wholesale/Wholesale – Drugs & Drug Proprietaries:
0.00%
PREVIOUS CLOSE
CHG
CHG%
$292.12
-0.15
0.00%
View ratios
Fiscal Date | 12-31-2024 | |
---|---|---|
Fiscal Quarter | Q1 2025 | |
Report Date | 02-05-2025 | |
Total revenue | 81.487 B | |
Cost of revenue | 78.929 B | |
Gross profit | 2.558 B | |
Operating expenses | 1.472 B | |
Selling general and admin | 1.472 B | |
Research and development | 0.000 | |
Total expenses | 1.852 B | |
Operating income | 706.254 M | |
Ebit | 648.380 M | |
Pretax income | 620.447 M | |
Income tax | 126.728 M | |
Net income basic | 0.000 | |
Net income | 493.719 M | |